Actualités > Our articles
Retour

An evaluation result, indicator of excellence

In July 2024, the IMS was given the highest score being an A by the Interdisciplinary Thematic Institutes during its mid-term evaluation.

What are the ITI (Interdisciplinary thematic institutes) ?

The ITI are the pilar of the research and training evolution of the University of Strasbourg. Lead by an international jury, the midterm evaluation is renewing the 13 initial ITI and certifying two new projects for the second step of the 2021-2028 program.

2024 is an important step for this program with the mid-term evaluation, carried out by an international jury chaired by Professor Michael Hengartner. Ten experts from different fields, including specialists in interdisciplinarity, educational innovation, and research-training experts, reviewed written files and interviewed ITI coordination teams.

Their point-of-view and global recommendation are founded on six fundamental criteria of the program:

  • Build the strength of the structure research
  • Reinforce the link between training and research for the benefit of student and PhD student. 
  • Stimulate the interdisciplinarity and the contribution in the understanding of major scientific and societal challenges.
  • Conduct cross-cutting collaborative actions based on existing structures, research units, components, and doctoral schools.
  • Increase the international attractivity and internationalization.
  • Galvanize the attractivity of the structure and its interaction with the society.

This assessment attests to the relevance and progress of projects, with assessments ranging from “excellent” to “insufficient.” Thus, ITIs reflect different degrees of maturity.

The aim of IMS in the ITI :

The IMS is one of the 13 ITIs that have been renewed, representing all existing ITIs prior to 2024.

IMS provides a multidisciplinary environment encompassing chemistry, biology, medicine, pharmacology, physics, in silico experimentation, and law. It offers training opportunities through specific courses and mentoring from master’s to PhD levels. IMS also facilitates technology transfer, fosters entrepreneurship through startup creation and industrial partnerships, disseminates knowledge to society, and serves as a hub for collaborative research in the Alsace region.

It builds on the foundation of the previous Labex Medalis, with a strong emphasis on education, technology transfer, and industry collaboration. IMS comprises 12 teams with nearly 200 collaborators, encompassing chemists, biologists, and biophysicists, who seemingly collaborate effectively.

IMS is an attractive and timely initiative with significant economic appeal. Its strengths span across various aspects of its operations, from its comprehensive training programs to its collaborative research environment and its commitment to technology transfer and entrepreneurship.

Composition du Jury international

  • Michael Hengartner, President of the Jury, Président of ETH Board, polytechnique federale school, Zürich
  • Grace Neville, researcher, University College Cork, Cork
  • Andrée Sursock, principal council member, Association of europeen university
  • Britta Eickholt, professor, Charité, Berlin
  • Hans-Joachim Freund, professor emeritus, Institut Fritz Haber, Company Max Planck, Berlin
  • Arwen Pearson, reseacher, Hambourg Univrsity, Hambourg
  • Stefano Casola, researcher, Institute of Molecular Oncology, Milan
  • Laurent Buisson, Director general, AgroParisTech, Saclay
  • Catherine Loisy, researcher, Ecole normale supérieure, Lyon
  • Bianca Vienni-Baptista, researcher, ETH, Zürich